Genetic Variation at the ADAMTS7 Locus is Associated with Reduced Severity of Coronary Artery Disease

Kenneth Chan,Xiangyuan Pu,Pratik Sandesara,Robin N. Poston,Iain A. Simpson,Arshed A. Quyyumi,Shu Ye,Riyaz S. Patel
DOI: https://doi.org/10.1161/jaha.117.006928
2017-01-01
Abstract:Background Genome‐wide association studies identified ADAMTS 7 as a risk locus for coronary artery disease ( CAD ). Functional studies suggest that ADAMTS 7 may promote cellular processes in atherosclerosis. We sought to examine the association between genetic variation at ADAMTS 7 and measures of atherosclerosis using histological, angiographic, and clinical outcomes data. Methods and Results The lead CAD ‐associated single‐nucleotide polymorphism rs3825807 at the ADAMTS 7 locus was genotyped. The G allele (reduced ADAMTS 7 function) was associated with a smaller fibrous cap ( P =0.017) and a smaller percentage area of α‐actin (smooth muscle cell marker) in the intima ( P =0.017), but was not associated with calcification or plaque thickness, following ex vivo immunohistochemistry analysis of human coronary plaques (n=50; mean age 72.2±11.3). In two independent cohorts (Southampton Atherosclerosis Study [n=1359; mean age 62.5±10.3; 70.1% men] and the Emory Cardiovascular Biobank [Em CAB ; n=2684; mean age 63.8±11.3; 68.7% men]), the G allele was associated with 16% to 19% lower odds of obstructive CAD (Southampton Atherosclerosis Study: odds ratio, 0.81; 95% confidence interval, 0.67–0.98; Em CAB : odds ratio, 0.84; 95% confidence interval, 0.75–0.95) with similar effects for multivessel, left anterior descending, and proximal CAD . Furthermore, each copy of the G allele was associated with lower angiographic severity Gensini score (Southampton Atherosclerosis Study, P =0.026; Em CAB , P <0.001), lower Sullivan Extent score (Southampton Atherosclerosis Study, P =0.029; Em CAB , P <0.001), and a 23% lower risk of incident revascularization procedures (EmCAB: hazard ratio, 0.76; 95% confidence interval, 0.59–0.98). There were no associations with all‐cause mortality or incident myocardial infarction. Conclusions Genetic variation at the ADAMTS 7 locus is associated with several complementary CAD phenotypes, supporting the emerging role of ADAMTS 7 in atherosclerosis and may represent a potential drug target.
What problem does this paper attempt to address?